First Time Loading...

Atreca Inc
NASDAQ:BCEL

Watchlist Manager
Atreca Inc Logo
Atreca Inc
NASDAQ:BCEL
Watchlist
Price: 0.092 USD 2.11% Market Closed
Updated: May 17, 2024

Atreca Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Atreca Inc
Interest Income Expense Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Atreca Inc
NASDAQ:BCEL
Interest Income Expense
$820k
CAGR 3-Years
-36%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$1.8B
CAGR 3-Years
8%
CAGR 5-Years
-7%
CAGR 10-Years
-19%
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$757m
CAGR 3-Years
35%
CAGR 5-Years
0%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$2.9B
CAGR 3-Years
-44%
CAGR 5-Years
-30%
CAGR 10-Years
-16%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$563.1m
CAGR 3-Years
78%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$221.8m
CAGR 3-Years
-13%
CAGR 5-Years
75%
CAGR 10-Years
N/A

See Also

What is Atreca Inc's Interest Income Expense?
Interest Income Expense
820k USD

Based on the financial report for Dec 31, 2022, Atreca Inc's Interest Income Expense amounts to 820k USD.

What is Atreca Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
42%

Over the last year, the Interest Income Expense growth was 310%. The average annual Interest Income Expense growth rates for Atreca Inc have been -36% over the past three years , 42% over the past five years .